Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BeiGene Ltd

BGNE
Current price
129.52 USD -0.48 USD (-0.37%)
Last closed 131.96 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 15 584 542 720 USD
Yield for 12 month -49.85 %
1Y
3Y
5Y
10Y
15Y
BGNE
21.11.2021 - 28.11.2021

BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; TEVIMBRA to treat various solid tumor and blood cancers; PARTRUVIX for the treatment of various solid tumor malignancies; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; POBEVCY to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC); BAITUOWEI, to treat breast and prostate cancers; TAFINLAR and MEKINIST to treat NSCLC and melanoma; VOTRIENT for advance renal cell carcinoma; AFINITOR for advance renal cell carcinoma, NET, SEGA, & breast cancers; and ZYKADIA to treat ALK + NSCLC. The company is also developing inhibitors comprising Sonrotoclax (BGB-11417), BGB-10188, BGB-21447, Ociperlimab (BGB-A1217), Surzebiclimab (BGB-A425), BGB-15025, BGB-26808, Lifirafenib (BGB-283), BGB-3245, BGB-30813, and BGB-43395; antibodies, including Zanidatamab, BGB-A445, and BGB-A3055, as well as BGB-16673, a BTK-targeted CDAC, and BGB-24714, a SMAC mimetic. It has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Nanjing Leads Biolabs Co., Ltd. The company was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands. Address: 94 Solaris Avenue, Grand Cayman, Cayman Islands, KY1-1108

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

272.77 USD

P/E ratio

Dividend Yield

Current Year

+2 458 779 000 USD

Last Year

+1 415 921 000 USD

Current Quarter

+634 409 000 USD

Last Quarter

+781 308 000 USD

Current Year

+1 994 923 000 USD

Last Year

-511 062 000 USD

Current Quarter

+505 877 000 USD

Last Quarter

+684 999 000 USD

Key Figures BGNE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 124 610 944 USD
Operating Margin TTM -60.62 %
PE Ratio
Return On Assets TTM -12.4 %
PEG Ratio
Return On Equity TTM -22.26 %
Wall Street Target Price 272.77 USD
Revenue TTM 2 458 778 880 USD
Book Value 33.83 USD
Revenue Per Share TTM 23.55 USD
Dividend Share
Quarterly Revenue Growth YOY 66.9 %
Dividend Yield
Gross Profit TTM -511 062 000 USD
Earnings Share -8.45 USD
Diluted Eps TTM -8.45 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin -35.86 %

Dividend Analytics BGNE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BGNE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BGNE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.4256
Price Sales TTM 6.3383
Enterprise Value EBITDA -11.9104
Price Book MRQ 4.1739

Financials BGNE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BGNE

For 52 weeks

132.95 USD 270.57 USD
50 Day MA 156.22 USD
Shares Short Prior Month 1 730 527
200 Day MA 178.63 USD
Short Ratio 7.43
Shares Short 1 727 708
Short Percent 5.88 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics